Zeldis Pharma

Zeldis Group of Companies is a pharmaceutical holding company that develops, manufactures, promotes, distributes cosmetics, medical products, dietary supplements and medicines. The holding's product portfolio includes funds sold in various segments of the retail market: in cosmetology, dermatology, otorhinolaryngology, pediatrics, and the general health sector.

Zeldis produces products from Librederm, Horse Power, Pediculen, TravelDream, Badger, Skipar, etc.

Retail chain

In 2017, the company began to develop the retail network of the Librederm brand, opening flagship monobrand boutiques of selective cosmetics in St. Petersburg, Nizhny Novgorod, Krasnodar and Moscow.

R&D

The own R&D laboratory is equipped with modern equipment for developing formulas and testing products. Cooperation with leading laboratories around the world allows the company to be among the first to use the innovative achievements of medicine, parapharmaceuticals and cosmetology and apply them in the creation of new products.

Production

Zeldis products are produced at domestic and foreign plants (Great Britain, Spain, Italy, Turkey, South Korea, etc.), in accordance with world quality standards GLP, GCP, GMP, ISO 9001. Each batch of products undergoes multi-stage quality control in production, control when imported into the Russian Federation, as well as directly when delivered to the finished product warehouse.

The priority area of ​ ​ investment activities of the Zeldis group of companies is the development and maintenance of a quality control system for manufactured and distributed products. All products produced by the company must undergo clinical testing at the bases of medical institutions of the Russian Federation.

History

2022: Appointment of Vladimir Malinnikov as CEO of the company

In June 2022, it became known about the appointment of Vladimir Malinnikov as the new general director of Zeldis Pharma. He replaced Oksana Krasnykh, who headed the manufacturer of cosmetic products under the Librederm brand from September 2021. Malinnikov until February 2022 was the general director of the Magnit Pharma network. Read more here.

2018: Librederm cosmetics launch at Tmall Global site

The Tmall Global trading platform, which is part of the Alibaba Group, approved the entry of the Librederm brand (from Zeldis Pharma) into the Chinese market - on August 8, 2018, the first flagship store of Russian cosmetics opened on the Tmall site. At the initial stage, investments in the promotion of the first cosmetic brand from Russia will amount to 15 million yuan. The growing interest of Chinese youth in personalized cosmetics, as well as Alibaba Group's strategic search for new partners in the beauty industries of Europe and Asia, are expected to help win over the consumer . Read more here.